0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Bacitracin"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Peptide Antibiotics Market Report 2025 - Product Thumbnail Image

Peptide Antibiotics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$4,750USDGBP
  • 6 Results (Page 1 of 1)
Loading Indicator

Bacitracin is an antibiotic used to treat a variety of bacterial infections, including those caused by Staphylococcus aureus, Streptococcus pyogenes, and Clostridium species. It is commonly used in the treatment of skin and soft tissue infections, as well as in the prevention of wound infections. Bacitracin is also used in the treatment of some systemic infections, such as endocarditis and meningitis. It is available in both topical and systemic forms, and is often used in combination with other antibiotics. Bacitracin is a key component of the Infectious Diseases Drugs market, as it is used to treat a wide range of bacterial infections. It is often used in combination with other antibiotics, and is available in both topical and systemic forms. This makes it a versatile and effective treatment option for a variety of bacterial infections. Some companies in the Bacitracin market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more